PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.304
https://www.valueinhealthjournal.com/article/S1098-3015(12)02017-7/fulltext
Title : PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM)- A Number Needed to Treat (NNT) Analysis
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02017-7&doi=10.1016/j.jval.2012.08.304
First page : A654
Section Title : Cancer
Open access? : No
Section Order : 1848
Categories :
Tags :
Regions :
ViH Article Tags :